These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 4885452

  • 1. Effects of vasoactive drugs on oxygen consumption in endotoxin shock.
    Anas P, Hardy JD.
    Arch Surg; 1969 Feb; 98(2):189-93. PubMed ID: 4885452
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oxygen utilization in experimental shock: survey of some recent studies.
    Anas P, Neely WA, Hardy JD.
    Am Surg; 1968 Oct; 34(10):706-10. PubMed ID: 5680927
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of vasoactive drugs in the treatment of shock.
    Berk JL.
    Surg Clin North Am; 1975 Jun; 55(3):721-8. PubMed ID: 1135753
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic alterations and results of treatment in patients with gram-negative septic shock.
    Motsay GJ, Dietzman RH, Ersek RA, Lillehei RC.
    Surgery; 1970 Apr; 67(4):577-83. PubMed ID: 4908041
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Basic principles of the therapy of shock].
    Schröder R.
    Minerva Med; 1972 Dec 26; 63(93):5243-6. PubMed ID: 4646406
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A, Reinhart K.
    Acta Anaesthesiol Scand Suppl; 1997 Dec 26; 111():177-80. PubMed ID: 9421002
    [No Abstract] [Full Text] [Related]

  • 11. Effects of infusion of isoprenaline sulfate and low molecular dextran on canine endotoxin shock.
    Kapur BM, Rao BN, Sarangee RK.
    Surgery; 1972 Apr 26; 71(4):507-12. PubMed ID: 5021067
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of vasoactive agents in shock therapy.
    Ogburn P.
    Vet Clin North Am; 1976 May 26; 6(2):287-95. PubMed ID: 775751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
    Misra SN, Kezdi P.
    Am J Cardiol; 1973 Jun 26; 31(6):724-35. PubMed ID: 4145230
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of volume resistant experimental shock by hypervolemia and hypothermia.
    Halmagyi DF, Frazer TA, Varga D.
    Surgery; 1973 Sep 26; 74(3):370-80. PubMed ID: 4579020
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of various treatments on renal function during endotoxin shock. An experimental study in dogs.
    Knuth OE, Wagenknecht LV, Madsen PO.
    Invest Urol; 1972 Jan 26; 9(4):304-9. PubMed ID: 5058769
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.